Wound Care: Preventing Diabetic Amputations: Modulim CEO Amaan Mazhar on Imaging and Early Detection

Every 20 seconds, someone in the world loses a limb to diabetes. Many of these amputations could be prevented with earlier detection. In this episode, Amaan Mazhar, CEO of Modulim, explains how handheld imaging can spot circulation issues before ulcers form. We cover the science behind spatial frequency domain imaging, the economics of diabetic foot ulcers, and how proactive screening can save both lives and costs.Episode Breakdown00:00 – The epidemic of lower limb complications in the US 02:01 – Amaan Mazhar’s journey into medtech and imaging science 03:38 – From UC Irvine research to founding Modulim 04:52 – Diabetic foot ulcers and why they are so costly 05:27 – Traditional foot checks and why they often fail 07:02 – Modulim’s imaging: seeing below the skin surface 09:17 – Biomarkers that predict wounds before they form 10:52 – Case study: detecting an ulcer 13 weeks before it appeared 12:06 – Spatial frequency domain imaging explained 13:23 – Pivot from cart system to handheld device 15:54 – Reducing manufacturing costs and expanding access 17:18 – Identifying micro vs macrovascular issues18:55 – Clinical traction with Kaiser Permanente and Fresenius 20:27 – Commercial model: hardware placement plus software subscription 22:01 – Expanding into military use for wound and burn assessment 25:03 – How the technology works: light patterns, multispectral imaging 27:21 – IP, UC Irvine partnership, and innovation pathway 28:10 – Regulatory strategy: 510(k) submission for handheld device29:35 – Market opportunity: 30–40 million patients at risk 31:04 – Early detection as a data gap and how Modulim can close it 32:28 – Closing thoughts and call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.#Medtech #Diabetes #AmputationPrevention #Diagnostics #HealthcareInnovation #DigitalHealth